Activating Ras-MAPK pathway variants drive hippocampal clonal competition in human epilepsy
Preprint
Abstract
Mesial ( a.k.a., medial) temporal lobe epilepsy (MTLE) is the most common focal epilepsy 1,2 and, in drug-resistant cases, is treated by surgical removal of the anterior temporal lobe, which often shows neuronal loss and gliosis consistent with hippocampal sclerosis (HS) 2 . MTLE with HS has minimal contribution from germline genetic variation 3 , and is associated with prior precipitating insults such as prolonged childhood seizures and head trauma 4–6 . Somatic variants in Ras-MAPK pathway genes were recently reported in a few MTLE surgical specimens 7,8 , but their prevalence, clinical relevance, and underlying biological mechanisms remain unknown. Targeted duplex sequencing of hippocampal DNA from 462 surgical resections revealed significant enrichment of deleterious somatic variants in MTLE versus controls, with >40% of MTLE specimens harboring activating Ras-MAPK variants in PTPN11 , NF1 , BRAF , KRAS , and twelve genes not previously associated with focal epilepsy. Eight Ras-MAPK genes showed positive clonal selection in MTLE. Increased somatic variant burden predicted worse surgical outcome. Somatic Ras-MAPK variants at ultra-low (9,10 ; in contrast, Alzheimer disease hippocampi exhibited microglial enrichment of Ras-MAPK variants, consistent with prior reports 11 . Single-nucleus RNA sequencing showed increased expression of Ras-MAPK genes in neurons and upregulation of pathways mediating neurogenesis and neural development in MTLE. Functional validation of novel, recurrent PTPN11 variants confirmed gain-of-function, while cellular modeling in induced pluripotent stem cells demonstrated proliferative/survival advantages for mutant cells in mosaic culture. Overall, our data suggest that somatic Ras-MAPK variants and acquired risk factors may converge on clonal competition in the hippocampus to modulate epilepsy risk.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (460333672-CRC1540)
This publication has 109 references indexed in Scilit:
- Epilepsy in cardiofaciocutaneous syndrome: Clinical burden and response to anti‐seizure medicationAmerican Journal of Medical Genetics Part A, 2023
- Contribution of Somatic Ras/Raf/Mitogen-Activated Protein Kinase Variants in the Hippocampus in Drug-Resistant Mesial Temporal Lobe EpilepsyJAMA Neurology, 2023
- Ultra‐Low Level Somatic Mutations and Structural Variations in Focal Cortical Dysplasia Type IIAnnals of Neurology, 2023
- Rare Genetic Variation and Outcome of Surgery for Mesial Temporal Lobe EpilepsyAnnals of Neurology, 2023
- Dose-dependent seizure control with MEK inhibitor therapy for progressive glioma in a child with neurofibromatosis type 1Child's Nervous System, 2022
- Dissecting the genetic basis of focal cortical dysplasia: a large cohort studyActa Neuropathologica, 2019
- Somatic SLC35A2 variants in the brain are associated with intractable neocortical epilepsyAnnals of Neurology, 2018
- Neurophysiologic and Neuroradiologic Features of Intractable Epilepsy After Traumatic Brain Injury in AdultsArchives of Neurology, 2000
- Cellular pathology of hilar neurons in Ammon's horn sclerosisJournal of Comparative Neurology, 1999
- Secondary Epileptogenesis in Cerebral Arteriovenous MalformationsArchives of Neurology, 1991